If your new drug saves money in other health areas then the PBS will pay. New drugs that prevent serious long term health problems (i.e. those that cost a fortune to treat) can save the health system money overall even if they cost a lot themselves. It is the overall spend that matters, not the prices of individual components.
I do wonder if you have shared your new found interest in health economics on your favourite company’s HC threads. Remind me how much do cell therapies cost per patient?
If your new drug saves money in other health areas then the PBS...
-
- There are more pages in this discussion • 505 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.000(0.00%) |
Mkt cap ! $289.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 580 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 1116 | 1 |
View Market Depth
| Last trade - 10.05am 18/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |
Day chart unavailable